China · Delayed Price · Currency is CNY Walvax Biotechnology Statistics
Total Valuation
SHE:300142 has a market cap or net worth of CNY 22.69 billion. The enterprise value is 23.49 billion.
| Market Cap | 22.69B |
| Enterprise Value | 23.49B |
Important Dates
The last earnings date was Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | Jan 9, 2026 |
Share Statistics
SHE:300142 has 1.60 billion shares outstanding. The number of shares has increased by 1.49% in one year.
| Current Share Class | 1.60B |
| Shares Outstanding | 1.60B |
| Shares Change (YoY) | +1.49% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 6.33% |
| Owned by Institutions (%) | 14.16% |
| Float | 1.45B |
Valuation Ratios
The trailing PE ratio is 79.97 and the forward PE ratio is 75.68.
| PE Ratio | 79.97 |
| Forward PE | 75.68 |
| PS Ratio | 9.46 |
| PB Ratio | 2.90 |
| P/TBV Ratio | 3.46 |
| P/FCF Ratio | 230.70 |
| P/OCF Ratio | 35.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.90, with an EV/FCF ratio of 238.81.
| EV / Earnings | 82.21 |
| EV / Sales | 9.79 |
| EV / EBITDA | 36.90 |
| EV / EBIT | 97.82 |
| EV / FCF | 238.81 |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.16 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 2.14 |
| Debt / FCF | 13.85 |
| Interest Coverage | 31.76 |
Financial Efficiency
Return on equity (ROE) is 2.69% and return on invested capital (ROIC) is 2.44%.
| Return on Equity (ROE) | 2.69% |
| Return on Assets (ROA) | 1.18% |
| Return on Invested Capital (ROIC) | 2.44% |
| Return on Capital Employed (ROCE) | 2.63% |
| Weighted Average Cost of Capital (WACC) | 6.21% |
| Revenue Per Employee | 1.21M |
| Profits Per Employee | 144,257 |
| Employee Count | 1,981 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.01 |
Taxes
In the past 12 months, SHE:300142 has paid 50.57 million in taxes.
| Income Tax | 50.57M |
| Effective Tax Rate | 16.32% |
Stock Price Statistics
The stock price has increased by +38.17% in the last 52 weeks. The beta is 0.42, so SHE:300142's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +38.17% |
| 50-Day Moving Average | 12.72 |
| 200-Day Moving Average | 12.30 |
| Relative Strength Index (RSI) | 57.64 |
| Average Volume (20 Days) | 88,297,311 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300142 had revenue of CNY 2.40 billion and earned 285.77 million in profits. Earnings per share was 0.18.
| Revenue | 2.40B |
| Gross Profit | 1.76B |
| Operating Income | 240.26M |
| Pretax Income | 309.82M |
| Net Income | 285.77M |
| EBITDA | 625.96M |
| EBIT | 240.26M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 970.10 million in cash and 1.36 billion in debt, with a net cash position of -392.87 million or -0.25 per share.
| Cash & Cash Equivalents | 970.10M |
| Total Debt | 1.36B |
| Net Cash | -392.87M |
| Net Cash Per Share | -0.25 |
| Equity (Book Value) | 7.81B |
| Book Value Per Share | 4.63 |
| Working Capital | 2.33B |
Cash Flow
In the last 12 months, operating cash flow was 632.36 million and capital expenditures -533.99 million, giving a free cash flow of 98.37 million.
| Operating Cash Flow | 632.36M |
| Capital Expenditures | -533.99M |
| Depreciation & Amortization | 385.70M |
| Net Borrowing | 867.85M |
| Free Cash Flow | 98.37M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 73.33%, with operating and profit margins of 10.01% and 11.91%.
| Gross Margin | 73.33% |
| Operating Margin | 10.01% |
| Pretax Margin | 12.91% |
| Profit Margin | 11.91% |
| EBITDA Margin | 26.08% |
| EBIT Margin | 10.01% |
| FCF Margin | 4.10% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 0.29%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 0.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 293.96% |
| Buyback Yield | -1.49% |
| Shareholder Yield | -1.20% |
| Earnings Yield | 1.26% |
| FCF Yield | 0.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 14, 2015. It was a forward split with a ratio of 3.
| Last Split Date | Oct 14, 2015 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
SHE:300142 has an Altman Z-Score of 4.39 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.39 |
| Piotroski F-Score | 6 |